We also found that proliferation and growth of glioma cancer stem cells were severely impaired upon knockdown of c-Myc, but importantly, the cell cycle progression of CD133− glioma cells were relatively insensitive to loss of c-Myc. The gene discussed is MYC; the disease is central nervous system cancer.